Trulance Immediate release is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals Inc.. The primary component is Plecanatide.
| Product ID | 65649-003_32e16caa-3e71-476b-a394-faf189345e2b |
| NDC | 65649-003 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Trulance Immediate release |
| Generic Name | Plecanatide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-02-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208745 |
| Labeler Name | Salix Pharmaceuticals Inc. |
| Substance Name | PLECANATIDE |
| Active Ingredient Strength | 3 mg/1 |
| Pharm Classes | Guanylate Cyclase-C Agonist [EPC],Guanylate Cyclase Activators [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2017-02-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208745 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-21 |
| Marketing Category | NDA |
| Application Number | NDA208745 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-21 |
| Marketing Category | NDA |
| Application Number | NDA208745 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-21 |
| Marketing Category | NDA |
| Application Number | NDA208745 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-21 |
| SPL SET ID: | fe2895bf-71a6-493a-b0ca-e06b2dfefc82 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 65649-003 | Trulance | Plecanatide |
| 70194-003 | Trulance | Plecanatide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRULANCE 87392678 5349314 Live/Registered |
BAUSCH HEALTH IRELAND LIMITED 2017-03-30 |
![]() TRULANCE 87042213 5242709 Live/Registered |
BAUSCH HEALTH IRELAND LIMITED 2016-05-18 |